Novocure is set to disclose its Q3 2025 financial results on October 30, providing key insights into its performance and strategic direction amidst a competitive landscape. This announcement is crucial for investors and stakeholders monitoring the company’s progress and impact on the oncology market.
BAAR, Switzerland–(BUSINESS WIRE)–Novocure (NASDAQ: NVCR) will report financial results for the third quarter 2025 on October 30, 2025, before the U.S. financial markets open. Novocure management will host a conference call and webcast at 8:00 a.m. EDT, October 30, to discuss the company’s financial results for the three- and nine-month periods that ended September 30, 2025. To access the conference call by phone, use the following conference call registration link and dial-in details will be
Source: Original Press Release